Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Experimental concerns regarding suPAR-related proteinuria.

Literature DB >> 28757634

Experimental concerns regarding suPAR-related proteinuria.

Laurent Mesnard¹, Yosu Luque¹, Eric Rondeau¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2017 PMID： 28757634 DOI： 10.1038/nrneph.2017.108

Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314

× No keyword cloud information.

11 in total

1. Glomerular disease: A suPAR kidney connection found in the bone marrow.

Authors: Lorenzo Gallon; Susan E Quaggin
Journal: Nat Rev Nephrol Date: 2017-03-13 Impact factor: 28.314

Review 2. Paroxysmal nocturnal hemoglobinuria.

Authors: Robert A Brodsky
Journal: Blood Date: 2014-09-18 Impact factor: 22.113

3. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors: Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal: Nat Med Date: 2011-07-31 Impact factor: 53.440

4. Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors: Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal: J Am Soc Nephrol Date: 2014-05-01 Impact factor: 10.121

5. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.

Authors: Elaine M Sloand; Loretta Pfannes; Phillip Scheinberg; Kenneth More; Colin O Wu; McDonald Horne; Neal S Young
Journal: Exp Hematol Date: 2008-10-26 Impact factor: 3.084

6. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors: M Ploug; J Eriksen; T Plesner; N E Hansen; K Danø
Journal: Eur J Biochem Date: 1992-09-01

7. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit.

Authors: S Honda; Y Tomiyama; A J Pelletier; D Annis; Y Honda; R Orchekowski; Z Ruggeri; T J Kunicki
Journal: J Biol Chem Date: 1995-05-19 Impact factor: 5.157

8. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.

Authors: Joann M Spinale; Laura H Mariani; Shiv Kapoor; Jidong Zhang; Robert Weyant; Peter X Song; Hetty N Wong; Jonathan P Troost; Crystal A Gadegbeku; Debbie S Gipson; Matthias Kretzler; Deepak Nihalani; Lawrence B Holzman
Journal: Kidney Int Date: 2014-10-29 Impact factor: 10.612

9. Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.

Authors: Eunsil Hahm; Changli Wei; Isabel Fernandez; Jing Li; Nicholas J Tardi; Melissa Tracy; Shikha Wadhwani; Yanxia Cao; Vasil Peev; Andrew Zloza; Jevgenijs Lusciks; Salim S Hayek; Christopher O'Connor; Markus Bitzer; Vineet Gupta; Sanja Sever; David B Sykes; David T Scadden; Jochen Reiser
Journal: Nat Med Date: 2016-12-12 Impact factor: 53.440